Risks with Cytoreductive Therapy
Video Categories: Polycythemia VeraSupported through funding from Incyte
Related Videos
Optimal Value-Based Therapy
Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.Supported through funding from Incyte
PMO Interview with the Innovator Series: Volume 4
Tom Reynolds, Chief Medical Officer of Seattle Genetics, offers a definition of personal medicine in this new video series from Personalized Medicine in Oncology.